Clinical Trials Directory

Trials / Completed

CompletedNCT00308906

Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children

Assessment of Gene and Urinary Protein Expression in Aminoglycoside-treated and Untreated Infants, Children and Adolescents

Status
Completed
Phase
Study type
Observational
Enrollment
166 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purposes of this study are to identify potential gene and protein markers of aminoglycoside-induced kidney injury in infants, children and adolescents treated with aminoglycoside antibiotics.

Conditions

Interventions

TypeNameDescription
DRUGaminoglycosideAminoglycosides will be administered and monitored as part of the routine standard of care for the subject.

Timeline

Start date
2006-06-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2006-03-30
Last updated
2016-02-02

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00308906. Inclusion in this directory is not an endorsement.

Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children (NCT00308906) · Clinical Trials Directory